Evidence map›Paper›PMID 11598010›Full record

ArticleThe EMBO journal2001

Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Y Kubota, T Tanaka, A Kitanaka, H Ohnishi, Y Okutani, M Waki, T Ishida, H Kamano

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Y KubotaDepartment of Transfusion Medicine, School of Medicine and Environmental Health Sciences, Kagawa Medical University, Kagawa 761-0793, Japan. ketsuken@kms.ac.jp
T Tanaka
A Kitanaka
H Ohnishi
Y Okutani
M Waki
T Ishida
H Kamano
Kagawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we examined the molecular mechanism of erythropoietin-initiated signal transduction of erythroid differentiation through Src and phosphatidylinositol 3-kinase (PI3-kinase). Antisense oligonucleotides against src but not lyn inhibited the formation of erythropoietin-dependent colonies derived from human bone marrow cells and erythropoietin-induced differentiation of K562 human erythroleukaemia cells. Antisense p85alpha oligonucleotide or LY294002, a selective inhibitor of PI3-kinase, independently inhibited the formation of erythropoietin-dependent colonies. In K562 cells, Src associated with PI3-kinase in response to erythropoietin. Antisense src RNA expression in K562 cells inhibited the erythropoietin-induced activation of PI3-kinase and its association with erythropoietin receptor. PP1, a selective inhibitor of the Src family, reduced erythropoietin-induced tyrosine phosphorylation of erythropoietin receptor and its association with PI3-kinase in F-36P human erythroleukaemia cells. The coexpression experiments and in vitro kinase assay further demonstrated that Src directly tyrosine-phosphorylated erythropoietin receptor, and associated with PI3-kinase. In vitro binding experiments proved that glutathione S-transferase-p85alpha N- or C-terminal SH2 domains independently bound to erythropoietin receptor, which was tyrosine-phosphorylated by Src. Taken together, Src transduces the erythropoietin-induced erythroid differentiation signals by regulating PI3-kinase activity.

Indexed as

AndrostadienesAnimalsBone Marrow CellsCell DifferentiationChlorocebus aethiopsChromonesColony-Forming Units AssayCOS CellsEnzyme ActivationEnzyme InhibitorsErythroid Precursor CellsErythropoietinGene Expression Regulation, LeukemicGenes, srcHumansK562 Cells2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAndrostadienesChromonesEnzyme InhibitorsErythropoietinlyn protein-tyrosine kinaseMacromolecular SubstancesMorpholinesNeoplasm ProteinsOligonucleotides, AntisensePhosphatidylinositol 3-KinasesProto-Oncogene Proteins pp60(c-src)Receptors, ErythropoietinRecombinant Proteinssrc-Family KinasesWortmannin

Identifiers

PMID11598010
PMCPMC125681
OpenAlexW1986021138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.